Payne HA - Search Results

1

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer.

Brown RS, Dogan A, Ell PJ, Payne HA, Masters JR, Harland SJ. Brown RS, et al. Among authors: payne ha. Prostate Cancer Prostatic Dis. 2002;5(2):144-51. doi: 10.1038/sj.pcan.4500581. Prostate Cancer Prostatic Dis. 2002. PMID: 12497005 Clinical Trial.

2

Trends in testicular carcinoma in England and Wales, 1971-99.

Power DA, Brown RS, Brock CS, Payne HA, Majeed A, Babb P. Power DA, et al. Among authors: payne ha. BJU Int. 2001 Mar;87(4):361-5. doi: 10.1046/j.1464-410x.2001.00078.x. BJU Int. 2001. PMID: 11251531

3

Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales.

Hayne D, Brown RS, McCormack M, Quinn MJ, Payne HA, Babb P. Hayne D, et al. Among authors: payne ha. Clin Oncol (R Coll Radiol). 2001;13(6):448-52. doi: 10.1053/clon.2001.9311. Clin Oncol (R Coll Radiol). 2001. PMID: 11824884

4

First report of an isolated jejunal seminoma: presentation with melaena and iron deficiency anaemia.

Brown RS, Yassin J, Colville DH, Harland SJ, Payne HA. Brown RS, et al. Among authors: payne ha. Clin Oncol (R Coll Radiol). 2001;13(6):455-7. doi: 10.1053/clon.2001.9313. Clin Oncol (R Coll Radiol). 2001. PMID: 11824886

5

Penile preservation in squamous cell carcinoma of the bulbomembranous urethra.

Christopher N, Arya M, Brown RS, Payne HA, Woodhouse CR, Ralph DJ. Christopher N, et al. Among authors: payne ha. BJU Int. 2002 Mar;89(4):464-5. doi: 10.1046/j.1464-4096.2001.00135.x. BJU Int. 2002. PMID: 11872045 No abstract available.

6

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.

Brown RS, Edwards J, Dogan A, Payne H, Harland SJ, Bartlett JM, Masters JR. Brown RS, et al. J Pathol. 2002 Oct;198(2):237-44. doi: 10.1002/path.1206. J Pathol. 2002. PMID: 12237884

7

Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

Birtle AJ, Freeman A, Payne HA, Masters JR, Harland SJ. Birtle AJ, et al. Among authors: payne ha. BJU Int. 2003 Sep;92(4):490. doi: 10.1046/j.1464-410x.2003.t01-1-04376.x. BJU Int. 2003. PMID: 12930449 No abstract available.

8

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.

Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Birtle AJ, et al. Among authors: payne ha. Cancer. 2003 Dec 1;98(11):2362-7. doi: 10.1002/cncr.11821. Cancer. 2003. PMID: 14635070 Free article.

9

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL.

Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Birtle AJ, et al. Among authors: payne ha. BJU Int. 2005 Aug;96(3):303-7. doi: 10.1111/j.1464-410X.2005.05619.x. BJU Int. 2005. PMID: 16042718

10

Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.

Al-Salihi O, Mitra A, Payne H. Al-Salihi O, et al. Prostate Cancer Prostatic Dis. 2006;9(4):370-3. doi: 10.1038/sj.pcan.4500893. Epub 2006 Jul 11. Prostate Cancer Prostatic Dis. 2006. PMID: 16832383 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters